{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:11:40Z","timestamp":1789582300219,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The aims of the present study are to evaluate non-invasive screening tests for autoimmune gastritis (AIG) and re-evaluate histopathological classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We screened candidates of AIG in JCHO Shiga Hospital between May 2012 and January 2020. The screening criteria were as follows: endoscopic O-p atrophy with Updated Kimura\u2013Takemoto classification, 3\u2009+\u2009pepsinogen (PG) test, low serum vitamin B\n                      <jats:sub>12<\/jats:sub>\n                      or elevated serum gastrin with positive anti-parietal cell (PC) or intrinsic factor antibodies. We evaluated the screening criteria in the patients who were histopathologically confirmed as AIG, and re-evaluated histopathological staging in clinical aspects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-two of 28 (78.6%) patients who met the screening criteria were histopathologically confirmed as AIG. Common clinical findings in the AIG patients were 10\u2009\u00d7\u2009or greater anti-PC antibody, elevated serum gastrin greater than 172\u00a0pg\/mL and endoscopic atrophy O-1 or greater. The areas under the curve of PG I, PG II and PG I\/II ratio were 0.81, 0.29 and 0.98, respectively. Among histopathologically confirmed AIG patients, 4 and 18 patients were histopathologically classified into florid and end stages, respectively, while no patients into early stage. We could not find a significant difference between florid and end stages in the screening items studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Florid and end stages in histopathological classification are both advanced-stage AIG in clinical aspects. Our screening criteria without biopsy are applicable to screen clinically-advanced AIG with 78.6% positive predictive value. PG I and PG I\/II ratio may be useful to screen AIG. However, we may need other criteria to screen early stage of AIG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-022-02251-8","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T08:04:12Z","timestamp":1649664252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of screening tests for autoimmune gastritis in histopathologically confirmed Japanese patients, and re-evaluation of histopathological classification"],"prefix":"10.1186","volume":"22","author":[{"given":"Yasuhiro","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1386-0985","authenticated-orcid":false,"given":"Shigemi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuki","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Chatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoyuki","family":"Hayafuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Kushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"2251_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/BF01071995","volume":"18","author":"RG Strickland","year":"1973","unstructured":"Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis. 1973;18:426\u201340.","journal-title":"Am J Dig Dis"},{"key":"2251_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12903-016-0215-y","volume":"16","author":"J Kim","year":"2016","unstructured":"Kim J, Kim MJ, Kho HS. Oral manifestations in vitamin B12 deficiency patients with or without history of gastrectomy. BMC Oral Health. 2016;16:60.","journal-title":"BMC Oral Health"},{"key":"2251_CR3","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.2169\/internalmedicine.2693-19","volume":"58","author":"M Kawanaka","year":"2019","unstructured":"Kawanaka M, Tanikawa T, Kamada T, et al. High prevalence of autoimmune gastritis in patients with nonalcoholic steatohepatitis. Intern Med. 2019;58:2907\u201313.","journal-title":"Intern Med"},{"key":"2251_CR4","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2169\/internalmedicine.2292-18","volume":"58","author":"T Notsu","year":"2019","unstructured":"Notsu T, Adachi K, Mishiro T, et al. Prevalence of autoimmune gastritis in individuals undergoing medical checkups in Japan. Intern Med. 2019;58:1817\u201323.","journal-title":"Intern Med"},{"key":"2251_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.imlet.2012.06.004","volume":"147","author":"A Cabrera de Le\u00f3n","year":"2012","unstructured":"Cabrera de Le\u00f3n A, Gonz\u00e1lez DA, Almeida AA, et al. Factors associated with parietal cell autoantibodies in the general population. Immunol Lett. 2012;147:63\u20136.","journal-title":"Immunol Lett"},{"key":"2251_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1158\/1055-9965.EPI-12-1343","volume":"22","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Weck MN, Sch\u00f6ttker B, et al. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013;22:821\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2251_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/den.13676","volume":"33","author":"S Nakajima","year":"2021","unstructured":"Nakajima S, Watanabe H, Shimbo T, et al. Incisura angularis belongs to fundic or transitional gland regions in Helicobacter pylori-na\u00efve normal stomach: sub-analysis of the prospective multi-center study. Dig Endosc. 2021;33:125\u201332.","journal-title":"Dig Endosc"},{"key":"2251_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-0028-1098086","volume":"1","author":"K Kimura","year":"1969","unstructured":"Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;1:87\u201397.","journal-title":"Endoscopy"},{"key":"2251_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1443-9573.2007.00278.x","volume":"8","author":"K Miki","year":"2007","unstructured":"Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8:8\u201314.","journal-title":"J Dig Dis"},{"key":"2251_CR10","first-page":"423","volume":"58","author":"N Mori","year":"2020","unstructured":"Mori N, Nakajima S, Takemura S, et al. Primary diagnosis of autoimmune gastritis without biopsy. J Gastrointest Cancer Screen. 2020;58:423\u201335 (in Japanese).","journal-title":"J Gastrointest Cancer Screen"},{"key":"2251_CR11","first-page":"140","volume-title":"Diagnostic pathology; gastrointestinal","author":"JK Greenson","year":"2019","unstructured":"Greenson JK, Lawers GY, Montgomery EA, et al. Diagnostic pathology; gastrointestinal. 3rd ed. Amsterdam: Elsevier; 2019. p. 140\u20133.","edition":"3"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"12179","DOI":"10.3748\/wjg.v21.i42.12179","volume":"21","author":"I Coati","year":"2015","unstructured":"Coati I, Fassan M, Farinati F, et al. Autoimmune gastritis: pathologist\u2019s viewpoint. World J Gastroenterol. 2015;21:12179\u201389.","journal-title":"World J Gastroenterol"},{"key":"2251_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00428-021-03033-5","volume":"479","author":"Y Wada","year":"2021","unstructured":"Wada Y, Nakajima S, Kushima R, et al. Pyloric, pseudopyloric, and spasmolytic polypeptide-expressing metaplasias in autoimmune gastritis: a case series of 22 Japanese patients. Virchows. 2021;479:169\u201378.","journal-title":"Virchows"},{"key":"2251_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/bmj.1.5794.209","volume":"1","author":"MG Korman","year":"1972","unstructured":"Korman MG, Laver MC, Hansky J. Hypergastrinaemia in chronic renal failure. Br Med J. 1972;1:209\u201310.","journal-title":"Br Med J"},{"key":"2251_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000188586","volume":"70","author":"H Nakahama","year":"1995","unstructured":"Nakahama H, Tanaka Y, Shirai D, et al. Elevated serum pepsinogens in chronic renal failure patients. Nephron. 1995;70:211\u20136.","journal-title":"Nephron"},{"key":"2251_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/den.13500","volume":"32","author":"S Terao","year":"2020","unstructured":"Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig Endosc. 2020;32:364\u201372.","journal-title":"Dig Endosc"},{"key":"2251_CR17","first-page":"47","volume":"46","author":"R Kes","year":"1992","unstructured":"Kes R. Serum gastrin concentration in chronic renal failure. Acta Med Croatica. 1992;46:47\u201358.","journal-title":"Acta Med Croatica"},{"key":"2251_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1053\/j.gastro.2010.08.023","volume":"139","author":"YX Yang","year":"2010","unstructured":"Yang YX, Metz DC. Safety of proton pump inhibitor exposure. Gastroenterology. 2010;139:1115\u201327.","journal-title":"Gastroenterology"},{"key":"2251_CR19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/sjg.SJG_573_16","volume":"23","author":"Z Li","year":"2017","unstructured":"Li Z, Wu C, Li L, et al. Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: a meta-analysis. Saudi J Gastroenterol. 2017;23:222\u20138.","journal-title":"Saudi J Gastroenterol"},{"key":"2251_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/BF01318685","volume":"31","author":"HP Festen","year":"1986","unstructured":"Festen HP, Tuynman HA, D\u00e9fize J, et al. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels. Dig Dis Sci. 1986;31:561\u20136.","journal-title":"Dig Dis Sci"},{"key":"2251_CR21","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/ajg.2009.231","volume":"104","author":"E Lahner","year":"2009","unstructured":"Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104:2071\u20139.","journal-title":"Am J Gastroenterol"},{"key":"2251_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/apt.14849","volume":"48","author":"T Furuta","year":"2018","unstructured":"Furuta T, Baba S, Yamade M, et al. High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. Aliment Pharmacol Ther. 2018;48:370\u20137.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02251-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:41:37Z","timestamp":1700412097000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02251-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02251-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1210431\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We conducted the present study according to the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects issued from the Japan Ministry of Health, Labour and Welfare in 2015. The present study was approved by the Institutional Review Board of JCHO Shiga Hospital (approval number 2018-16).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The present study is a retrospective observational study and the study participants did not give written informed consent. Those who wanted to withdraw from the study were given a chance to opt out of the study as recommended by the Ethical Guidelines for Medical and Health Research Involving Human Subjects issued from the Japan Ministry of Health, Labour and Welfare. Table and figures did not contain any non-anonymous data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}